Edwards Lifesciences Corp (NYSE:EW)
| 80.72 Delayed Data As of Mar 24 |  +1.17 / +1.47%Today’s Change | 67.13 Today|||52-Week Range 131.10 | +8.19% Year-to-Date |
Latest EW News | Press Releases
| HOLX vs. EW: Which Stock Is the Better Value Option? Mar 23 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 79.55 |
| Today’s open | 79.72 |
| Day’s range | 79.62 - 81.00 |
| Volume | 2,759,103 |
| Average volume (3 months) | 4,099,795 |
| Market cap | $49.1B |
Data as of 3:59pm ET, 03/24/2023
Growth & Valuation
| Earnings growth (last year) | +1.95% |
| Earnings growth (this year) | +1.55% |
| Earnings growth (next 5 years) | +8.49% |
| Revenue growth (last year) | +2.86% |
| P/E ratio | 33.1 |
| Price/Sales | 8.65 |
| Price/Book | 8.46 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| STESTERIS plc | +3.91 | +2.16% |
| SNNSmith & Nephew PLC | -0.30 | -1.07% |
| ---- | ||
| ISRGIntuitive Surgical | +12.01 | +4.91% |
Data as of 4:00pm ET, 03/24/2023
Financials
| Next reporting date | April 25, 2023 |
| EPS forecast (this quarter) | $0.61 |
| Annual revenue (last year) | $5.4B |
| Annual profit (last year) | $1.5B |
| Net profit margin | 28.28% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Irvine, California |
Forecasts
